All Topics

Subscribe
Article
Crypto Brief
This weekly digest from Lowenstein Crypto examines critical regulatory developments shaping the digital asset landscape, including the OCC's findings on banking restrictions for crypto businesses, the EU's classification of USDC as a significant e-money token, Australia's proposed standards for crypto exchanges, and the FSB's concerns about cross-border stablecoin oversight. The report highlights how regulatory frameworks are evolving to address operational challenges while balancing innovation and financia
United States Finance
LS
Lowenstein Sandler
Article
Ankura CTIX FLASH Update – October 20, 2026
Ankura's October 2026 insights explore emerging threats and strategic challenges across cybersecurity, healthcare capital planning, tax optimization, and operational efficiency. From sophisticated malware targeting Web3 startups to hidden costs eroding retail margins, these analyses reveal critical pressure points facing modern organizations. How can leaders navigate mounting complexity while protecting value and maintaining competitive advantage?
United States Strategy
AC
Ankura Consulting Group LLC
Video
Consumer Counterpoint Quick Take: TCPA Default Judgment Denied As Court Rejects Cellphone And Text Claims (Video)
A Southern District of Florida judge recently declined to enter a default judgment against a defendant in a TCPA case, determining that the term 'residential telephone subscriber' under 227(c)(1) does not extend to cell phones. This decision has significant implications for how telecommunications consumer protection laws apply to mobile devices versus traditional landlines.
United States Consumer
SS
Seyfarth Shaw LLP
Article
UPDATE: DEA Publishes Registration Applications For Medical Marijuana Manufacturers, Distributors, And Analytical Labs
The DEA has opened new registration portals for medical marijuana manufacturers, distributors, and analytical labs, expanding beyond the dispensary registration that became available earlier this year. These applications require extensive business information and background disclosures, with fees ranging from $296 to $3,699, and may provide significant compliance and commercial benefits for cannabis businesses operating under state medical marijuana programs.
United States Government
FH
Foley Hoag LLP
See more